Literature DB >> 18820409

Axon regeneration after spinal cord injury: insight from genetically modified mouse models.

Jae K Lee1, Binhai Zheng.   

Abstract

The use of genetically modified mice to study axon regeneration after spinal cord injury has served as a useful in vivo model for both loss-of-function and gain-of-function analysis of candidate proteins. This review discusses the impact of genetically modified mice on axon regeneration after spinal cord injury in the context of axon growth inhibition by myelin, the glial scar, and chemorepellent molecules. We also discuss the use of mice which transgenically express fluorescent proteins in specific axons for increasing our understanding of how spinal cord axons behave after injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820409      PMCID: PMC2646464     

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  46 in total

1.  Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein.

Authors:  T GrandPré; F Nakamura; T Vartanian; S M Strittmatter
Journal:  Nature       Date:  2000-01-27       Impact factor: 49.962

2.  Injury-induced class 3 semaphorin expression in the rat spinal cord.

Authors:  F De Winter; M Oudega; A J Lankhorst; F P Hamers; B Blits; M J Ruitenberg; R J Pasterkamp; W H Gispen; J Verhaagen
Journal:  Exp Neurol       Date:  2002-05       Impact factor: 5.330

3.  Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes.

Authors:  V Menet; M Prieto; A Privat; M Giménez y Ribotta
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

4.  Role of EphA4 and EphrinB3 in local neuronal circuits that control walking.

Authors:  Klas Kullander; Simon J B Butt; James M Lebret; Line Lundfald; Carlos E Restrepo; Anna Rydström; Rudiger Klein; Ole Kiehn
Journal:  Science       Date:  2003-03-21       Impact factor: 47.728

5.  Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.

Authors:  S Jung; J Aliberti; P Graemmel; M J Sunshine; G W Kreutzberg; A Sher; D R Littman
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

6.  Chondroitinase ABC promotes functional recovery after spinal cord injury.

Authors:  Elizabeth J Bradbury; Lawrence D F Moon; Reena J Popat; Von R King; Gavin S Bennett; Preena N Patel; James W Fawcett; Stephen B McMahon
Journal:  Nature       Date:  2002-04-11       Impact factor: 49.962

7.  Axon regeneration in young adult mice lacking Nogo-A/B.

Authors:  Ji Eun Kim; Shuxin Li; Tadzia GrandPré; Dike Qiu; Stephen M Strittmatter
Journal:  Neuron       Date:  2003-04-24       Impact factor: 17.173

8.  Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth.

Authors:  Vicky Kottis; Pierre Thibault; Daniel Mikol; Zhi-Cheng Xiao; Rulin Zhang; Pauline Dergham; Peter E Braun
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

9.  Stable in vivo imaging of densely populated glia, axons and blood vessels in the mouse spinal cord using two-photon microscopy.

Authors:  Dimitrios Davalos; Jae K Lee; W Bryan Smith; Brendan Brinkman; Mark H Ellisman; Binhai Zheng; Katerina Akassoglou
Journal:  J Neurosci Methods       Date:  2007-11-28       Impact factor: 2.390

10.  Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.

Authors:  Kevin C Wang; Vuk Koprivica; Jieun A Kim; Rajeev Sivasankaran; Yong Guo; Rachel L Neve; Zhigang He
Journal:  Nature       Date:  2002-06-16       Impact factor: 49.962

View more
  6 in total

1.  Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice.

Authors:  E Masliah; F Xie; S Dayan; E Rockenstein; M Mante; A Adame; C M Patrick; A F Chan; B Zheng
Journal:  Neuroscience       Date:  2010-04-28       Impact factor: 3.590

Review 2.  Signaling pathways in reactive astrocytes, a genetic perspective.

Authors:  Wenfei Kang; Jean M Hébert
Journal:  Mol Neurobiol       Date:  2011-01-14       Impact factor: 5.590

Review 3.  Identifying the role of microRNAs in spinal cord injury.

Authors:  Jun Dong; Meng Lu; Xijing He; Junkui Xu; Jie Qin; Zhijian Cheng; Baobao Liang; Dong Wang; Haopeng Li
Journal:  Neurol Sci       Date:  2014-09-18       Impact factor: 3.307

4.  Oligodendrocytic but not neuronal Nogo restricts corticospinal axon sprouting after CNS injury.

Authors:  Jessica M Meves; Cédric G Geoffroy; Noah D Kim; Joseph J Kim; Binhai Zheng
Journal:  Exp Neurol       Date:  2018-07-25       Impact factor: 5.330

5.  Restoration of Visual Function by Enhancing Conduction in Regenerated Axons.

Authors:  Fengfeng Bei; Henry Hing Cheong Lee; Xuefeng Liu; Georgia Gunner; Hai Jin; Long Ma; Chen Wang; Lijun Hou; Takao K Hensch; Eric Frank; Joshua R Sanes; Chinfei Chen; Michela Fagiolini; Zhigang He
Journal:  Cell       Date:  2016-01-14       Impact factor: 41.582

Review 6.  The Role of microRNA Markers in the Diagnosis, Treatment, and Outcome Prediction of Spinal Cord Injury.

Authors:  Nikolay L Martirosyan; Alessandro Carotenuto; Arpan A Patel; M Yashar S Kalani; Kaan Yagmurlu; G Michael Lemole; Mark C Preul; Nicholas Theodore
Journal:  Front Surg       Date:  2016-11-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.